Approaches and challenges in SARS-CoV-2 vaccine development

G Dagotto, J Yu, DH Barouch - Cell host & microbe, 2020 - cell.com
The explosive spread of SARS-CoV-2 suggests that a vaccine will be required to end this
global pandemic. Progress in SARS-CoV-2 vaccine development to date has been faster …

Humoral immune responses in COVID-19 patients: a window on the state of the art

G Siracusano, C Pastori, L Lopalco - Frontiers in immunology, 2020 - frontiersin.org
The novel SARS-CoV-2 is a recently emerging virus causing a human pandemic. A great
variety of symptoms associated with COVID-19 disease, ranging from mild to severe …

A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2

A Grifoni, J Sidney, Y Zhang, RH Scheuermann… - Cell host & …, 2020 - cell.com
Effective countermeasures against the recent emergence and rapid expansion of the 2019
novel coronavirus (SARS-CoV-2) require the development of data and tools to understand …

[HTML][HTML] Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies

SF Ahmed, AA Quadeer, MR McKay - Viruses, 2020 - mdpi.com
The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel
coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an …

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies

C Dobaño, R Santano, A Jiménez, M Vidal, J Chi… - Translational …, 2021 - Elsevier
COVID-19 patients elicit strong responses to the nucleocapsid (N) protein of SARS-CoV-2
but binding antibodies are also detected in prepandemic individuals, indicating potential …

Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes

A Poran, D Harjanto, M Malloy, CM Arieta… - Genome medicine, 2020 - Springer
Background The ongoing COVID-19 pandemic has created an urgency to identify novel
vaccine targets for protective immunity against SARS-CoV-2. Early reports identify protective …

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected …

H Hofmann, K Hattermann, A Marzi… - Journal of …, 2004 - Am Soc Microbiol
The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) causes severe
pneumonia with a fatal outcome in approximately 10% of patients. SARS-CoV is not closely …

[HTML][HTML] Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2

MT Khan, MJ Islam, A Parihar, R Islam, TJ Jerin… - Informatics in medicine …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmittable
and pathogenic human coronavirus that caused a pandemic situation of acute respiratory …

The aetiology, origins, and diagnosis of severe acute respiratory syndrome

LLM Poon, Y Guan, JM Nicholls, KY Yuen… - The Lancet infectious …, 2004 - thelancet.com
Severe acute respiratory syndrome (SARS) is a new infectious disease that first emerged in
Guangdong province, China, in November, 2002. A novel coronavirus was later identified in …

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome …

EN van den Brink, J Ter Meulen, F Cox… - Journal of …, 2005 - Am Soc Microbiol
Human monoclonal antibodies (MAbs) were selected from semisynthetic antibody phage
display libraries by using whole irradiated severe acute respiratory syndrome (SARS) …